Ranibizumab (RG-6321), a humanized monoclonal antibody fragment, targets and inhibits vascular endothelial growth factor A (VEGF-A), recognizing all its isoforms including VEGF110, VEGF121, and VEGF165. This anti-VEGF agent is effective in slowing vision loss in vivo and is primarily utilized in research focused on wet age-related macular degeneration (AMD).
Ranibizumab (RG-6321), a humanized monoclonal antibody fragment, targets and inhibits vascular endothelial growth factor A (VEGF-A), recognizing all its isoforms including VEGF110, VEGF121, and VEGF165. This anti-VEGF agent is effective in slowing vision loss in vivo and is primarily utilized in research focused on wet age-related macular degeneration (AMD).
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
